CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,513,389
+$1,670,814 QoQ
Shares Held
182,887
-0.8% QoQ
Ownership
0.913%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.98797071415683.ToString("F0")%
Shared 0.ToString("F0")%
None 0.01202928584317092.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. LGND ranks #37 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,513,389 | 182,887 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,842,575 | 184,284 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $32,295,279 | 182,315 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $20,014,955 | 176,064 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,755,412 | 168,874 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $18,260,395 | 170,419 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $16,407,153 | 163,924 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,088,948 | 155,340 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,948,625 | 149,776 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $11,532,901 | 161,480 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,418,645 | 157,187 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,134,114 | 154,426 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,823,103 | 147,133 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,264,216 | 168,626 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,625,875 | 160,577 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,853,200 | 159,064 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,840,657 | 154,481 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,763,114 | 153,213 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,494,295 | 143,758 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $11,226,279 | 137,173 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,318,298 | 129,526 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,513,342 | 121,105 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,154,172 | 120,312 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,193,564 | 103,096 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $4,721,624 | 104,081 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||